Linghua J. Meng

No. 19A Yuquan Road
Yuquan, 100049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Chem-Stamp Empowered Discovery of a Novel ATRA-Based LDLR Up-Regulator for the Treatment of Atherosclerosis.

Chem-Stamp Empowered Discovery of a Novel ATRA-Based LDLR Up-Regulator for the Treatment of Atherosclerosis.

Journal: Journal of medicinal chemistry

Published: July 21, 2026

Remote Sensing of Soil Water Retention Signatures Using Sentinel-2 Time-Series and Exponential Decay Fitting Model.

Remote Sensing of Soil Water Retention Signatures Using Sentinel-2 Time-Series and Exponential Decay Fitting Model.

Journal: Sensors (Basel, Switzerland)

Published: May 07, 2026

N‑Iminopyridinium Ylides as Chemically Stable Pharmacophores Enabling Targeted Degradation of SMARCA Proteins.

N‑Iminopyridinium Ylides as Chemically Stable Pharmacophores Enabling Targeted Degradation of SMARCA Proteins.

Journal: JACS Au

Published: January 06, 2026

Design, synthesis and pharmacological evaluation of new SMARCA2 degraders bearing a furo[3,2-c]pyridazine scaffold.

Design, synthesis and pharmacological evaluation of new SMARCA2 degraders bearing a furo[3,2-c]pyridazine scaffold.

Journal: European journal of medicinal chemistry

Published: December 07, 2025

Clinical characteristics of severe human metapneumovirus infection in children and analysis of risk factors for critical illness

Clinical characteristics of severe human metapneumovirus infection in children and analysis of risk factors for critical illness

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: July 22, 2025

Targeting intrinsic and CAF-mediated signaling by PI3Kα inhibitor CYH33 attenuated metastasis in lung squamous cell carcinoma.

Targeting intrinsic and CAF-mediated signaling by PI3Kα inhibitor CYH33 attenuated metastasis in lung squamous cell carcinoma.

Journal: Acta pharmacologica Sinica

Published: June 14, 2025

Swinging the SWI/SNF complexes for cancer therapy.

Swinging the SWI/SNF complexes for cancer therapy.

Journal: Trends in pharmacological sciences

Published: June 10, 2025

Design, synthesis and structure-activity relationship studies of novel macrocyclic 2,4-diaminopyrimidines as HPK1 inhibitors.

Design, synthesis and structure-activity relationship studies of novel macrocyclic 2,4-diaminopyrimidines as HPK1 inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: February 27, 2025

Design, Synthesis, and Pharmacological Evaluation of Quinazoline and Quinoline Derivatives as Potent ENPP1 Inhibitors for Cancer Immunotherapy.

Design, Synthesis, and Pharmacological Evaluation of Quinazoline and Quinoline Derivatives as Potent ENPP1 Inhibitors for Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: February 20, 2025

JMC14: a novel dual PI3Kδ/CSF1R inhibitor with potent antitumor activity in hematological and solid tumors.

JMC14: a novel dual PI3Kδ/CSF1R inhibitor with potent antitumor activity in hematological and solid tumors.

Journal: Acta pharmacologica Sinica

Published: January 25, 2025

PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors.

PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors.

Journal: Cell death & disease

Published: January 15, 2025

Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In Vivo.

Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In Vivo.

Journal: Journal of medicinal chemistry

Published: January 13, 2025

Showing 1-12 of 53

Last Updated: 09/26/2026